FUNDC2 interacts with SLC25A11, a mitochondrial glutathione transporter, to regulate mitochondrial GSH (mitoGSH) levels, which affects ferroptosis . In experiments, knockout of FUNDC2 protected mice from doxorubicin-induced cardiac injury by preventing ferroptosis .
FUNDC2 deficiency inhibited cell death and lipid ROS accumulation induced by SASP/BSO/RSL3, indicating that FUNDC2 mediates ferroptosis, likely through modulating mitochondrial GSH .
FUNDC2-KO increases the SLC25A11 level and blocks the erastin-induced reduction of GPX4 and mitochondrial proteins .
Ferroptosis is an iron-dependent cell death mechanism that is influenced by mitochondrial activity .
High GSH levels, especially mitoGSH, appear to be cardioprotective against doxorubicin-induced cardiotoxicity .
Depleting mitoGSH with MitoCDNB enhances erastin-induced cell death, suggesting that mitoGSH depletion increases erastin-induced cell death .
FUNDC2's interaction with SLC25A11 is crucial for its role in regulating mitoGSH levels and ferroptosis .
FUNDC2 has implications in diseases and conditions such as:
Doxorubicin-induced cardiomyopathy: Knockout of FUNDC2 protects against cardiac injury by preventing ferroptosis .
Triple-Negative Breast Cancer (TNBC): FUNDC2 expression is significantly higher in TNBC tissues compared to luminal subtype breast cancer tissues, suggesting a role in TNBC progression .
Hemophilia A and Factor VIII Deficiency: Diseases associated with the FUNDC2 gene .
The following data illustrate the effects of FUNDC2 knockout (KO) and its impact on GSH levels in cardiac tissue:
| Measurement | WT Group | FUNDC2-KO Group | Effect of DOX in WT | Effect of DOX in FUNDC2-KO |
|---|---|---|---|---|
| Total GSH/GSSG Ratio | Lower | Higher | Reduced by ~50% | Preserved |
| Mitochondrial GSH/GSSG Ratio | Lower | Higher | Reduced by ~50% | Preserved |
| Total GSH Levels | Lower | Higher | Reduced by ~50% | Preserved |
| Mitochondrial GSH Levels | Lower | Higher | Reduced by ~50% | Preserved |
WT = Wild Type; DOX = Doxorubicin
A robust method to confidently characterize proteins from an incomplete sequence database of Macaca mulatta, uses PEAKS de novo sequencing software, facilitating the use of this animal model in various neuroproteomics studies .
The most abundant peptide fragments 'b-ions and y-ions', the less abundant peptide fragments 'a-ions' as well as the immonium ions were utilized to develop confident and complete peptide sequences de novo from MS/MS spectra .
The generated sequences were used to perform homology searches to characterize the protein identification .
FUNDC2 belongs to the FUN14 domain-containing protein family, which includes the better-characterized FUNDC1. While specific information about FUNDC2 functions is limited, FUNDC1 serves as an integral mitochondrial outer-membrane protein that mediates the formation of mitochondria-associated endoplasmic reticulum membranes (MAMs) . FUNDC1 has been implicated in angiogenesis, hypoxia-induced mitophagy, and hepatic ferroptosis, suggesting potential related functions for FUNDC2 . Research approaches for FUNDC2 would likely parallel those used for FUNDC1, including protein localization studies, interaction partner identification, and functional assays under various cellular stresses.
Macaca mulatta (rhesus macaque) represents an invaluable non-human primate model for biomedical research due to its close evolutionary relationship with humans . Approximately 86% of human genes are represented in macaque transcriptomes, making them excellent models for studying human-relevant protein functions . The species-specificity of the immune system necessitates studying proteins like FUNDC2 in appropriate models when investigating immune-related disorders or when developing therapeutic approaches . The high genetic similarity between macaques and humans allows for more reliable extrapolation of experimental results to human applications compared to rodent models.
RNA isolation from Macaca mulatta tissues for recombinant protein expression studies should follow established protocols using reagents like Trizol (Invitrogen) . The process involves:
Tissue homogenization in Trizol reagent
RNA extraction following manufacturer's protocol
Validation of RNA quality by electrophoresis in formaldehyde-containing agarose gels to confirm intact 28S and 18S ribosomal RNA bands
mRNA subtraction using poly(A) tract isolation systems (e.g., PolyA Tract mRNA isolation system by Promega)
First-strand cDNA synthesis using oligo(dT) primers and reverse transcriptase
This approach ensures high-quality RNA for downstream applications like PCR amplification of the target gene.
When designing primers for Macaca mulatta FUNDC2 amplification, consider the following methodology:
Obtain reference sequences from databases like NCBI for both human and available macaque FUNDC2 sequences
Identify conserved regions between human and macaque sequences to design primers
Design primers with appropriate restriction sites for subsequent cloning
Ensure primers have compatible melting temperatures (within 2-3°C of each other)
Validate primer specificity using in silico PCR tools
Include appropriate overhangs for the selected expression system
For example, when amplifying genes from M. mulatta, researchers have successfully used polymerase chain reaction (PCR) with specifically designed primers containing restriction sites compatible with the intended expression vector .
Alternative splicing (AS) events significantly impact protein diversity and function in primates. Based on transcriptome studies in Macaca fascicularis, approximately 4,314 AS events have been identified across various tissues . Intriguingly, 10.4% of AS events are associated with transposable element (TE) insertions, which could potentially affect FUNDC2 expression and function . When investigating FUNDC2 variants:
Perform tissue-specific transcriptome analysis to identify potential FUNDC2 splice variants
Examine intron-exon boundaries for potential alternative splice sites
Validate predicted variants using RT-PCR and sequencing
Compare expression patterns of different splice variants across tissues
Assess functional differences between splice variants using in vitro assays
Understanding these variants is crucial as they may confer tissue-specific functions or differential responses to cellular stress conditions.
While specific data on FUNDC2 post-translational modifications (PTMs) is limited, studies on related proteins like FUNDC1 suggest PTMs play crucial roles in regulating function. For FUNDC1, phosphorylation states regulate mitophagy activity and interaction with binding partners like LC3 . To investigate PTMs in FUNDC2:
Perform mass spectrometry analysis of purified recombinant FUNDC2 to identify potential PTM sites
Create phosphomimetic and phosphodeficient mutants through site-directed mutagenesis
Compare wild-type and mutant FUNDC2 function in cellular assays
Investigate kinases and phosphatases that may regulate FUNDC2 activity
Assess how cellular stress conditions (hypoxia, oxidative stress) affect FUNDC2 PTM patterns
Understanding these modifications would provide insights into how FUNDC2 activity is regulated in different cellular contexts.
Tissue-specific expression analysis is critical for understanding protein function in context. In transcriptome studies of Macaca fascicularis, 175 tissue-specific transcripts were identified across 16 different tissues . While specific FUNDC2 expression data is not provided in the search results, a methodological approach to determine this would include:
Quantitative RT-PCR analysis of FUNDC2 expression across multiple tissues
RNA-Seq analysis of different tissues to obtain expression profiles
Western blot analysis using FUNDC2-specific antibodies to confirm protein expression
Immunohistochemistry to localize FUNDC2 in tissue sections
Such analysis would reveal whether FUNDC2 shows preferential expression in specific tissues, providing clues to its physiological functions.
When selecting an expression system for recombinant Macaca mulatta FUNDC2, consider the following options and their methodological implications:
For Macaca mulatta proteins, P. pastoris has been successfully used to express recombinant proteins with yields of approximately 3-4 mg from 1 L of inductive media . The choice should be guided by the intended application and required protein characteristics.
Functional assessment of recombinant FUNDC2 requires multiple complementary approaches:
Binding assays to identify interaction partners:
Co-immunoprecipitation with potential binding partners
Surface plasmon resonance to determine binding kinetics
Yeast two-hybrid screening to discover novel interactions
Subcellular localization studies:
Fluorescent tagging and microscopy
Subcellular fractionation and Western blotting
Protease protection assays for topology determination
Cell-based functional assays:
If FUNDC2 functions similarly to FUNDC1, assess its potential role in mitophagy through co-localization with LC3 under various stress conditions and its impact on mitochondrial dynamics .
The Experimental Design Assistant (EDA) provides valuable guidance for designing experiments with non-human primates . Key considerations include:
Sample size calculation:
Use power analysis to determine the minimum number of animals required
Consider variability in FUNDC2 expression levels between individuals
Randomization and blinding:
Implement randomization in treatment group assignments
Ensure analysis is performed blind to treatment conditions
Controls and validation:
Include appropriate positive and negative controls
Validate antibody specificity for macaque FUNDC2
Use multiple methodologies to confirm findings
Ethical considerations:
Additionally, construct a visual representation of your experimental plan using tools like the EDA to facilitate transparency and collaboration with colleagues .
Optimizing Western blot protocols for macaque FUNDC2 requires careful consideration of several factors:
Sample preparation:
Use appropriate tissue/cell lysis buffers with protease inhibitors
Optimize protein extraction protocols for subcellular fractions (especially for mitochondrial proteins)
Antibody selection:
Protocol optimization:
Determine optimal primary antibody dilution (typically start with 1:1000)
Optimize blocking conditions to reduce background
Consider using PVDF membranes for better protein retention and sensitivity
Controls:
Given the high sequence similarity between human and macaque proteins, antibodies designed for human FUNDC1/FUNDC2 detection may work for macaque samples, but validation is essential .
Understanding evolutionary differences between macaque and human FUNDC2 requires comparative analysis:
Sequence comparison:
Perform alignment analysis of FUNDC2 sequences from both species
Identify conserved domains and species-specific variations
Calculate sequence identity percentages for different functional domains
Structural analysis:
Predict protein structures using homology modeling
Compare functional motifs and potential binding sites
Identify differences that might affect protein-protein interactions
Functional comparison:
While specific FUNDC2 comparison data is not available, transcriptome sequencing of Macaca fascicularis shows approximately 86% of human genes are represented among the genes sequenced, suggesting high but not complete conservation .
Selecting appropriate models for studying FUNDC2 interactions with mitochondrial quality control machinery should consider:
Cell line models:
Macaque-derived cell lines for species-specific interactions
Human cell lines for translational relevance
Knockout/knockdown systems to study loss-of-function effects
Primary cell models:
Primary fibroblasts or myoblasts from macaque tissues
Primary neurons for studying mitochondrial dynamics in neuronal contexts
In vitro reconstitution:
Purified recombinant proteins for direct interaction studies
Isolated mitochondria for functional assays
Stress conditions to examine:
If FUNDC2 functions similarly to FUNDC1, it may interact with mitochondrial quality control machinery under stress conditions, making stress-response models particularly valuable .
Transcriptome sequencing provides powerful insights into gene regulation. Based on studies with Macaca fascicularis, the following methodological approaches would be valuable:
Tissue-specific expression profiling:
Alternative splicing analysis:
Regulatory network identification:
Such analysis could reveal regulatory mechanisms controlling FUNDC2 expression under different physiological conditions and in response to cellular stresses.
Based on knowledge of related proteins and general mitochondrial biology, promising research directions include:
Defining the role of FUNDC2 in mitophagy and mitochondrial quality control
Investigating FUNDC2 involvement in cellular responses to metabolic stress
Exploring potential roles in disease models where mitochondrial dysfunction is implicated
Comparing functions between macaque and human FUNDC2 to evaluate translational potential
Identifying small molecules that modulate FUNDC2 activity for experimental tools
These directions would build upon known functions of FUN14 domain-containing proteins while exploring the specific roles of FUNDC2.
Cross-species comparative studies offer valuable insights for translational research:
Identification of conserved functional domains that are likely essential for FUNDC2 function
Discovery of species-specific adaptations that might affect drug responses
Development of more predictive preclinical models for testing therapeutics targeting mitochondrial pathways
Understanding evolutionary adaptations in mitochondrial quality control mechanisms
Identification of compensatory mechanisms that might exist in one species but not another
Given that approximately 86% of human genes are represented in macaque transcriptomes, macaques provide a strong model for studying human-relevant functions while acknowledging potential species differences .
Emerging technologies that could advance FUNDC2 research include:
CRISPR/Cas9 gene editing:
Generation of precise knockouts or tagged endogenous proteins in macaque cells
Introduction of human variants to study functional differences
Proximity labeling techniques:
BioID or APEX2 fusion proteins to identify proximal interactors in living cells
Mapping the spatial organization of FUNDC2 in mitochondrial membranes
Advanced imaging:
Super-resolution microscopy to visualize mitochondrial dynamics
Live-cell imaging with fluorescent sensors to monitor mitochondrial function
Single-cell transcriptomics: